MedPath
TGA Approval

TRASTUCIP trastuzumab 150 mg powder for injection vial (368972)

368972

TRASTUCIP trastuzumab 150 mg powder for injection vial

Cipla Australia Pty Ltd

July 18, 2022

Medicine

Medicine

Active

Registered

Active Ingredients

Trastuzumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRASTUCIP trastuzumab 150 mg powder for injection vial (368972) - TGA 批准文号 | MedPath